Methacryloxypropyl Terminated PolyDimethylsiloxane cSt 50-90, 100g

5-bromo-N-(sec-butyl)-2-furamide, 95.0%, 1g

3,4-Bis-trifluoromethyl-benzoic acid, 95.0%, 100mg

Olmutinib, 90%, 5mg

3-Amino-5-nitrobenzotrifluoride, 97.0%, 100g

H-Tyr(tBu)-Ome HCl, 95.0%, 1g

4-(methylthio)-N-(tetrahydrofuran-2-ylmethyl)-1,3-benzothiazol-2-amine, 95.0%, 500mg

8-Bromo-3,4-dihydronaphthalen-2(1H)-one, 95.0%, 5g

(2-Aminopyrimidin-4-yl)methanol, 95.0%, 250mg

1-(2-Bromophenyl)ethanol, 97.0%, 100g

5-Bromo-2-chloro-N,N-dimethyl-3-pyridinecarboxamide, 97%, 5g

Cyclopent-3-enecarboxamide, 95.0%, 1g

5-CHLORO-6-METHYLPYRAZINE-2-CARBOXYLIC ACID, 95.0%, 100mg